Most Read Articles
Pearl Toh, 08 Jun 2016
Middle East Respiratory Syndrome (MERS) patients have more severe illness and a higher mortality rate than non-MERS severe acute respiratory infection (SARI) patients, according to a study presented at the recent American Thoracic Society (ATS) International Conference 2016 held in San Francisco, California, US.
Roshini Claire Anthony, 19 Sep 2016

Benralizumab reduced asthma exacerbations and improved lung function in patients with severe, eosinophilic asthma, according to results of the SIROCCO* and CALIMA** trials which were presented at the European Respiratory Society (ERS) International Congress 2016 held in London, UK.

01 Feb 2016
Ampicillin/sulbactam is an effective first-line therapy among elderly patients with Nursing- and Healthcare- associated Pneumonia (NHCAP), as observed in a retrospective analysis.
21 Apr 2016
At a recent continuing medical education programme, Dr Neil G Snowise, Regional Medical Leader of GlaxoSmithKline Global Respiratory Franchise shed light on the clinical efficacy of Relvar® Ellipta® (fluticasone furoate/vilanterol) for the management of asthma. Highlights of his presentation are summarized below.

Evolution of influenza vaccines – A broader protection for patients with chronic respiratory diseases and lung cancer

07 Aug 2017
Prof Yong Kek Pang Consultant Respiratory Physician University of Malaya Medical Centre

Persons with underlying medical conditions are at higher risk of influenza-associated hospitalization. At the recent Malaysian Thoracic Society (MTS) Congress 2017 held in Kuala Lumpur, Professor Pang spoke on the importance of influenza vaccination in patients with chronic respiratory disease and lung cancer, highlighting the benefits of quadrivalent influenza vaccines (QIVs) in providing wider spectrum of protection against influenza types A and B.
Look out for our upcoming Symposium Highlight article to find out more about how FluQuadriTM can help  your patients stay healthy.   

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 08 Jun 2016
Middle East Respiratory Syndrome (MERS) patients have more severe illness and a higher mortality rate than non-MERS severe acute respiratory infection (SARI) patients, according to a study presented at the recent American Thoracic Society (ATS) International Conference 2016 held in San Francisco, California, US.
Roshini Claire Anthony, 19 Sep 2016

Benralizumab reduced asthma exacerbations and improved lung function in patients with severe, eosinophilic asthma, according to results of the SIROCCO* and CALIMA** trials which were presented at the European Respiratory Society (ERS) International Congress 2016 held in London, UK.

01 Feb 2016
Ampicillin/sulbactam is an effective first-line therapy among elderly patients with Nursing- and Healthcare- associated Pneumonia (NHCAP), as observed in a retrospective analysis.
21 Apr 2016
At a recent continuing medical education programme, Dr Neil G Snowise, Regional Medical Leader of GlaxoSmithKline Global Respiratory Franchise shed light on the clinical efficacy of Relvar® Ellipta® (fluticasone furoate/vilanterol) for the management of asthma. Highlights of his presentation are summarized below.